Originally published bySydney Morning Herald
NeuroScientific Biopharmaceuticals has reported an 80% response rate from five Crohn’s disease patients treated with its StemSmart cell therapy, with all patients showing improvement.
🇦🇺
More news from AustraliaAustralia
OCEANIA
Related News
Could native forests be Cement Australia's 'sustainable' fuel option?
5h ago
Fowler wins FA Cup with Man City as fans honour Aussie coach's late father
3h ago
Blast at building storing explosives in Myanmar kills more than 45 people
7h ago
Will Panthers stars back up from Origin for top-of-the table clash with Warriors?
1d ago
Where is New Zealand’s best brunch? Share your favourite spots
1d ago